Targeted delivery combined with controlled drug release has a pivotal role in the future of personalized medicine. This review covers the principles, advantages, and drawbacks of passive and active targeting based on various polymer and magnetic iron oxide nanoparticle carriers with drug attached by both covalent and noncovalent pathways. Attention is devoted to the tailored conjugation of targeting ligands (e.g., enzymes, antibodies, peptides) to drug carrier systems. Similarly, the approaches toward controlled drug release are discussed. Various polymer-drug conjugates based, for example, on polyethylene glycol (PEG), N-(2-hydroxypropyl)methacrylamide (HPMA), polymeric micelles, and nanoparticle carriers are explored with respect to absorption, distribution, metabolism, and excretion (ADME scheme) of administrated drug. Design and structure of superparamagnetic iron oxide nanoparticles (SPION) and condensed magnetic clusters are classified according to the mechanism of noncovalent drug loading involving hydrophobic and electrostatic interactions, coordination chemistry, and encapsulation in porous materials. Principles of covalent conjugation of drugs with SPIONs including thermo- and pH-degradable bonds, amide linkage, redox-cleavable bonds, and enzymatically-cleavable bonds are also thoroughly described. Finally, results of clinical trials obtained with polymeric and magnetic carriers are analyzed highlighting the potential advantages and future directions in targeted anticancer therapy.
Ultra-low-fouling poly[N-(2-hydroxypropyl) methacrylamide] (poly(HPMA)) brushes have been synthesized for the first time. Similar to the so far only ultra-low-fouling surface, poly(carboxybetaine acrylamide), the level of blood plasma fouling was below the detection limit of surface plasmon resonance (SPR, 0.03 ng·cm(-2)) despite being a hydrogen bond donor and displaying a moderate wettability, thus challenging the currently accepted views for the design of antifouling properties. The antifouling properties were preserved even after two years of storage. To demonstrate the potential of poly(HPMA) brushes for the preparation of bioactive ultra-low fouling surfaces a label-free SPR immunosensor for detection of G Streptococcus was prepared.
We describe experiments pertaining to the formation of surface-anchored poly(acrylic acid) (PAA)
brushes with a gradual variation of the PAA grafting densities on flat surfaces and provide detailed analysis of
their properties. The PAA brush gradients are generated by first covering the substrate with a molecular gradient
of the polymerization initiator, followed by the “grafting from” polymerization of tert-butyl acrylate (tBA) from
these substrate-bound initiator centers, and finally converting the PtBA into PAA. We use spectroscopic ellipsometry
to measure the wet thickness of the grafted PAA chains in aqueous solutions at three different pH values (4, 5.8,
and 10) and a series of ionic strengths (IS). Our measurements reveal that at low grafting densities, σ, the wet
thickness of the PAA brush (H) remains relatively constant, the polymers are in the mushroom regime. Beyond
a certain value of σ, the macromolecules enter the brush regime, where H increases with increasing σ. For a
given σ, H exhibits a nonmonotonic behavior as a function of the IS. At large IS, the H is small because the
charges along PAA are completely screened by the excess of the external salt. As IS decreases, the PAA enters
the so-called salt brush (SB) regime, where H increases. At a certain value of IS, H reaches a maximum and then
decreases again. The latter is a typical brush behavior in so-called osmotic brush (OB) regime. We provide
detailed discussion of the behavior of the grafted PAA chains in the SB and OB regimes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.